Page 226 - 2025中醫藥與天然藥物聯合學術研討會-中醫藥與天然藥物的挑戰X機遇與未來大會手冊
P. 226

PP-44


               Loganin reduces cellular senescence and mitochondrial dysfunction induced

               by paclitaxel in skeletal muscle cells


                                           #,1
                                                                      1,2
                                                                                                        1,2
               Y u -Fan Chuang (莊雨凡),  Cai-Rong Wu (吳彩榕),  Wan-Hsuan Chang (張婉萱),
                                       1,2
               Ying-Jung Su (蘇盈蓉),  Yi-Ching Lo (羅怡卿)*           ,1,2,3

               1  Department of Pharmacology, School of Medicine, College of Medicine, Kaohsiung
                 Medical University, Kaohsiung 80708, Taiwan
               2  Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University,
                 Kaohsiung 80708, Taiwan
               3  Department of Traditional Medicine, School of Medicine, College of Medicine, Kaohsiung
                 Medical University, Kaohsiung 80708, Taiwan
               * E-mail: yichlo@kmu.edu.tw

               Abstract
                  Cellular  senescence,  marked  by  permanent  cell  cycle  arrest  and  senescence-associated
               secretory phenotype (SASP)-driven inflammation, contributes to skeletal muscle dysfunction.
               Paclitaxel,  a  common  chemotherapeutic  drug,  induces  skeletal  muscle  toxicity  through
               premature  cellular  senescence  and  mitochondrial  dysfunction.  In  this  study,  we  examined
               whether  loganin,  a  natural  iridoid  glycoside,  could  prevent  these  effects  in  C2C12  cells.
               Loganin pretreatment significantly suppressed senescence markers, including p21 expression,
               NFκB  activation,  Cdkn1a/Il6  upregulation,  and  SA-β-gal  positivity.  Moreover,  it  preserved
               mitochondrial  DNA  content,  membrane  potential,  and  ATP  levels,  while  reducing
               mitochondrial ROS accumulation, highlighting its role in maintaining mitochondrial integrity.
               Furthermore, loganin activated the SIRT1-AMPK axis and upregulated PGC-1α, TFAM, and
               NRF1 to promote mitochondrial biogenesis, linking pathway activation to functional outcomes.
               Together,  these  results  indicate  that  loganin  possesses  novel  protection  against  paclitaxel-
               induced cellular senescence and mitochondrial dysfunction, suggesting loganin as a promising
               candidate for improving muscle health during chemotherapy and warranting further in vivo
               investigation.

               Keywords:  Cellular  senescence;  Loganin;  Mitochondrial  biogenesis;  Paclitaxel;  Skeletal
               muscle
   221   222   223   224   225   226   227   228   229   230   231